Phenobarbitone induced drug reaction with eosinophilia and systemic symptoms (DRESS): a case report

Authors

  • Navreet K. Natt Medical officer, CHC Manawala, Amritsar, India
  • Tarsem Singh Department of Paediatrics, Sri Guru Ram Das Institute of Medical Sciences and Research, Vallah, Amritsar, India
  • Harmanjit Singh Department of Pharmacology, PGIMER, Chandigarh, India
  • Manu Sharma Department of Paediatrics, Sri Guru Ram Das Institute of Medical Sciences and Research, Vallah, Amritsar, India
  • Gagandeep Singh Department of Paediatrics, Sri Guru Ram Das Institute of Medical Sciences and Research, Vallah, Amritsar, India

Keywords:

Phenobarbitone, Adverse drug reactions, Anti-epileptics

Abstract

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a life threatening cutaneous drug reaction with visceral involvement and hematological abnormalities. Being a rare side effect, it is often under-reported and misdiagnosed. The fatal adverse drug reaction is associated most commonly with aromatic anti-epileptics phenytoin, carbamazepine and less frequently with phenobarbitone. Here, we report a case of phenobarbitone induced DRESS in a 1 year old male child. He succumbed to fulminant hepatic failure inspite of being put on steroids, hepatoprotectives, antibiotics and ventilatory support.

References

Yang CY, Dao RL, Lee TJ, Lu CW, Yang CH, Hung SI, et al. Severe cutaneous adverse reactions to antiepileptic drugs in Asians. Neurology 2011;77:2025-33.

Krauss G. Current understanding of delayed anticonvulsant hypersensitivity reactions. Epilepsy Curr 2006;6:33-7.

Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity: report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med 1950;242:897-8.

Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 1996;15:250-7.

Tas S, Simonart T. Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update. Dermatology 2003;206:353-6.

Gennis MA, Vemuri R, Burns EA, et al. Familial occurrence of hypersensitivity to phenytoin. Am J Med 1991;91:631-4.

Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:2285-90.

Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007;156:609-11.

Kim CW, Choi GS, Yun CH, Kim DI. Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome. J Korean Med Sci 2006;21:768-72.

Criado PR, Criado RF, Avancini Jde M, Santi CG. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol 2012;87:435-49.

Downloads

Published

2017-01-30

How to Cite

Natt, N. K., Singh, T., Singh, H., Sharma, M., & Singh, G. (2017). Phenobarbitone induced drug reaction with eosinophilia and systemic symptoms (DRESS): a case report. International Journal of Basic & Clinical Pharmacology, 2(3), 333–335. Retrieved from https://www.ijbcp.com/index.php/ijbcp/article/view/1266

Issue

Section

Case Reports